EP0829259A1 - Foam/gel with microbeads and/or fine particles - Google Patents

Foam/gel with microbeads and/or fine particles Download PDF

Info

Publication number
EP0829259A1
EP0829259A1 EP97306637A EP97306637A EP0829259A1 EP 0829259 A1 EP0829259 A1 EP 0829259A1 EP 97306637 A EP97306637 A EP 97306637A EP 97306637 A EP97306637 A EP 97306637A EP 0829259 A1 EP0829259 A1 EP 0829259A1
Authority
EP
European Patent Office
Prior art keywords
shaving cream
gel
beads
oil
powders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP97306637A
Other languages
German (de)
French (fr)
Inventor
Navin Manohar Geria
Joseph Melillo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of EP0829259A1 publication Critical patent/EP0829259A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/025—Explicitly spheroidal or spherical shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q9/00—Preparations for removing hair or for aiding hair removal
    • A61Q9/02—Shaving preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Definitions

  • This invention relates to foams and gels such as shaving creams for personal hygiene use and, in particular, to such foams and gels containing microbeads, fine particles or a combination of both.
  • Foams and gels for personal hygiene are well known.
  • foams and gels for personal hygiene are well known.
  • foams and gels are delivered to the user via a number of different, known methods, including aerosol sprays, so called "post-foaming" gels such as disclosed in US Patent No. 3,541,581, pump sprays and other non-aerosol sprays.
  • post-foaming gels such as disclosed in US Patent No. 3,541,581, pump sprays and other non-aerosol sprays.
  • Each of these various foams and gels contain a number of ingredients, both active and inactive, which provide the desired objective of the product.
  • none of the known foams or gels contain beads which contain active ingredients or powders which provide abrasion to the skin.
  • the present invention is directed to foams and gels for personal hygiene use which contain beads having an active ingredient, fine particles such as powders, or a combination of both beads and powders.
  • the beads may be microencapsulated and contain any one or more of a variety of ingredients, while the powders may be of a suitable form to cause mild abrasion to remove dead skin cells.
  • microparticles in the form of beads, powders or a combination of both, to the shaving cream or gel addresses the problem of an accumulation of debris, including dead skin cells, on the surface of the skin.
  • the microparticles act to scrub off the accumulation of debris on the skin and act in a uniform and fast manner because heavy scrubbing is not required.
  • the addition of microparticles to a post-foaming gel offers particular benefits in that upon application it provides gentle, deep cleaning to the skin.
  • the microparticles help weaken and loosen the dead, dry skin cells and other debris and the washing portion of shaving washes the debris from the skin. Consequently, the skin is retextured and fresher and will lead to future shaves being closer and more comfortable because there will be fewer lumps and bumps caused by debris for the razor to catch on the nick.
  • the formula for the cream or gel may be any formula known in the art or contemplated by one in the art.
  • various formulas are commercialized by numerous companies, including the Vitamins and Fine Chemicals Group of Hoffmann-Laroche, Nutley, New Jersey, Aqualon Company of Wilmington, Delaware, R.T. Vanderbilt Company, Inc. of Norwalk, Connecticut, Eastman Chemical Company of Kingsport, Tennessee, and Florasynth Inc. of Teterboro, New Jersey. None of the currently available formulas for shaving creams or gels, however, include powder, microbeads or a combination of both.
  • powders to a shaving cream or gel formula provides the user with the benefit of a mechanism for enhancing the exfoliation of dead skin cells through abrasion.
  • the powder also acts to remove any other debris, such as that caused by air pollution, which has accumulated on the skin.
  • the removal of such debris and the consequent unplugging of skin pores can create a healthier skin and prevent such diseases as acne.
  • the removal of the debris enhances the individual's complexion in that it exposes the newest, freshest layer of skin.
  • the powders, microbeads or combination thereof may be added in virtually any proportion to any shaving cream or gel formula.
  • Many different powder materials are suitable for inclusion in a shaving cream. Such materials include crushed nut shells (preferably walnut or almond shells), crushed apricot seeds, loofah, talc, magnesium stearate, chalk, kaolin, zinc oxide, titanium oxide, coated powders, beads, micro-silica beads (preferably those with 90/10 ratio), boron nitride, zinc stearate, magnesium oxide, cellulose powders, nylon powder or polyamid resin, silk powder protein, silk coated pigments, calcium carbonate, magnesium carbonate, mica, sericite or combinations thereof.
  • organic plastic powders such as polymethylmethacrylate beads, polyethylene beads and micropowders, polyvinylidene talc, polytetrafluoroethylene (teflon), polyamides, polyurethane, polystyrene or combinations thereof may be employed. While the powders may be readily obtained from many sources, Lipo Chemicals, Inc. of Paterson, New Jersey provides many powders in the above list in an acceptable form.
  • powder materials are synthetic clay, including magnesium lithium sodium silicate and silica, including silicon oxide spheres.
  • a preferred embodiment of the silicon oxide spheres comprises spheres which are size 7 to 14 microns, with a surface area of 200-400 square meters/gram and a density of 36-72 gram/liter.
  • the other preferred microbeads and powders may if possible be of a similar particle size.
  • the listed powder materials may be used in any desired ratio, mixture or concentration.
  • the powder materials may be used in any combination and any listed powder material may be used together with any other listed powder material.
  • microencapsulated particles may also be included in the formula.
  • the particles may contain various active or inactive ingredients which provide the formula with certain properties, such as enhanced lubrication or fragrance.
  • One such type of microparticle is alginate microspheres as provided by Lipo Technologies, Inc of Vandalia, Ohio.
  • Such microparticles may also be in the form of microcapsules.
  • the microcapsules basically comprise a core material of hydrophobic ingredients surrounded by a capsule wall which protects the core from the surroundings, while the microspheres comprises a hydrogel matrix which encapsulates the core material.
  • the core material may comprise any active or inactive material, such as a lubricant, which is activated upon exposure to water during shaving.
  • Additional materials such as jojoba oil, mineral oil, sesame oil, silicone oil, aloe vera oil, tocopheryl acetate, fragrance, vitamin E, dimethicone, allantoin, lanolin, sodium PCA, color, vitamin A, vitamin C, glycolic acid, glycerin, petrolatum, propane, isobutane or combinations thereof may also be employed within the microparticles, with the ratio and mixture dependent upon the desired properties of the final product.
  • pearlescent beads which contain active ingredients.
  • the beads are crushable such that during the application of the shaving cream or gel to the face the beads are crushed, thereby releasing their active material to the skin.
  • pearlescent beads is LipoPearl ⁇ as commercialized by Lipo Technologies, Inc.
  • Various materials may be included within the beads, including jojoba oil, mineral oil, sesame oil, silicon oil, aloe vera oil, tocopheryl acetate, fragrance, vitamin E, dimethicone, allantoin, lanolin, sodium PCA, color, vitamin A, vitamin C, glycolic acid, glycerin, petrolatum, propane, isobutane or combinations thereof.
  • Florabeads® as commercialized by International Flora Technologies, Ltd. of Apache Junction, Arizona.
  • the Florabeads® contain hydrogenated jojoba oil which acts as an exfoliant.

Abstract

The present invention is directed to foams and gels for personal hygiene use which contain beads having an active ingredient, fine particles such as powders, or a combination of both beads and powders. The beads may be microencapsulated and contain any one or more of a variety of ingredients, while the powders may be of a suitable form to cause mild abrasion to remove dead skin cells.

Description

This invention relates to foams and gels such as shaving creams for personal hygiene use and, in particular, to such foams and gels containing microbeads, fine particles or a combination of both.
Foams and gels for personal hygiene are well known. Among the many types of such foams and gels are shaving creams, pre-shave compositions, shampoos and liquid soaps. Such foams and gels are delivered to the user via a number of different, known methods, including aerosol sprays, so called "post-foaming" gels such as disclosed in US Patent No. 3,541,581, pump sprays and other non-aerosol sprays. Each of these various foams and gels contain a number of ingredients, both active and inactive, which provide the desired objective of the product. However, none of the known foams or gels contain beads which contain active ingredients or powders which provide abrasion to the skin.
The present invention is directed to foams and gels for personal hygiene use which contain beads having an active ingredient, fine particles such as powders, or a combination of both beads and powders. The beads may be microencapsulated and contain any one or more of a variety of ingredients, while the powders may be of a suitable form to cause mild abrasion to remove dead skin cells.
Accordingly, it is an advantage of the present invention to provide a foam, gel or post-foaming gel which contains beads having an active material, powder which provides abrasion to the skin or a combination of both.
There now follows a description of a preferred embodiment of the invention, by way of example.
Skin cells are formed and naturally replaced during a cycle which encompasses approximately 21 days. Consequently, a large number of dead skin cells are constantly building up on the surface of the skin. In addition, various other debris, such as that caused by air pollution, also accumulates on the surface of the skin. This accumulation of debris prevents the skin's freshest, newest layer from being exposed and consequently dulls the complexion. Numerous forms of shaving creams, gels and post-foaming gels, both aerosol and non-aerosol, for shaving are known in the art. For example, US Patent No. 3,541,581 issued to Monson and hereby incorporated by reference, describes post-foaming gels and a package for containing such gels. Virtually all of these products which are commercially available provide the benefits of moistening the beard and lubricating the skin before shaving. None of these known products, however, address the problems of dead skin cell build up or the accumulation of debris on the face.
The addition of microparticles in the form of beads, powders or a combination of both, to the shaving cream or gel, addresses the problem of an accumulation of debris, including dead skin cells, on the surface of the skin. The microparticles act to scrub off the accumulation of debris on the skin and act in a uniform and fast manner because heavy scrubbing is not required. The addition of microparticles to a post-foaming gel offers particular benefits in that upon application it provides gentle, deep cleaning to the skin. The microparticles help weaken and loosen the dead, dry skin cells and other debris and the washing portion of shaving washes the debris from the skin. Consequently, the skin is retextured and fresher and will lead to future shaves being closer and more comfortable because there will be fewer lumps and bumps caused by debris for the razor to catch on the nick.
The formula for the cream or gel may be any formula known in the art or contemplated by one in the art. For example, various formulas are commercialized by numerous companies, including the Vitamins and Fine Chemicals Group of Hoffmann-Laroche, Nutley, New Jersey, Aqualon Company of Wilmington, Delaware, R.T. Vanderbilt Company, Inc. of Norwalk, Connecticut, Eastman Chemical Company of Kingsport, Tennessee, and Florasynth Inc. of Teterboro, New Jersey. None of the currently available formulas for shaving creams or gels, however, include powder, microbeads or a combination of both.
The addition of powders to a shaving cream or gel formula provides the user with the benefit of a mechanism for enhancing the exfoliation of dead skin cells through abrasion. In addition, the powder also acts to remove any other debris, such as that caused by air pollution, which has accumulated on the skin. The removal of such debris and the consequent unplugging of skin pores can create a healthier skin and prevent such diseases as acne. Further, the removal of the debris enhances the individual's complexion in that it exposes the newest, freshest layer of skin.
The powders, microbeads or combination thereof may be added in virtually any proportion to any shaving cream or gel formula. Many different powder materials are suitable for inclusion in a shaving cream. Such materials include crushed nut shells (preferably walnut or almond shells), crushed apricot seeds, loofah, talc, magnesium stearate, chalk, kaolin, zinc oxide, titanium oxide, coated powders, beads, micro-silica beads (preferably those with 90/10 ratio), boron nitride, zinc stearate, magnesium oxide, cellulose powders, nylon powder or polyamid resin, silk powder protein, silk coated pigments, calcium carbonate, magnesium carbonate, mica, sericite or combinations thereof. In addition, organic plastic powders, such as polymethylmethacrylate beads, polyethylene beads and micropowders, polyvinylidene talc, polytetrafluoroethylene (teflon), polyamides, polyurethane, polystyrene or combinations thereof may be employed. While the powders may be readily obtained from many sources, Lipo Chemicals, Inc. of Paterson, New Jersey provides many powders in the above list in an acceptable form.
Other possible powder materials are synthetic clay, including magnesium lithium sodium silicate and silica, including silicon oxide spheres. A preferred embodiment of the silicon oxide spheres comprises spheres which are size 7 to 14 microns, with a surface area of 200-400 square meters/gram and a density of 36-72 gram/liter. The other preferred microbeads and powders may if possible be of a similar particle size. The listed powder materials may be used in any desired ratio, mixture or concentration. In addition, the powder materials may be used in any combination and any listed powder material may be used together with any other listed powder material.
In order to provide additional properties to the shaving cream or gel formula, microencapsulated particles may also be included in the formula. The particles may contain various active or inactive ingredients which provide the formula with certain properties, such as enhanced lubrication or fragrance. One such type of microparticle is alginate microspheres as provided by Lipo Technologies, Inc of Vandalia, Ohio. Such microparticles may also be in the form of microcapsules. The microcapsules basically comprise a core material of hydrophobic ingredients surrounded by a capsule wall which protects the core from the surroundings, while the microspheres comprises a hydrogel matrix which encapsulates the core material. In either version, the core material may comprise any active or inactive material, such as a lubricant, which is activated upon exposure to water during shaving. Additional materials, such as jojoba oil, mineral oil, sesame oil, silicone oil, aloe vera oil, tocopheryl acetate, fragrance, vitamin E, dimethicone, allantoin, lanolin, sodium PCA, color, vitamin A, vitamin C, glycolic acid, glycerin, petrolatum, propane, isobutane or combinations thereof may also be employed within the microparticles, with the ratio and mixture dependent upon the desired properties of the final product.
Another form of microparticle which may be included in the formula is pearlescent beads which contain active ingredients. Preferably, the beads are crushable such that during the application of the shaving cream or gel to the face the beads are crushed, thereby releasing their active material to the skin. One example of pearlescent beads is LipoPearl Ô as commercialized by Lipo Technologies, Inc. Various materials may be included within the beads, including jojoba oil, mineral oil, sesame oil, silicon oil, aloe vera oil, tocopheryl acetate, fragrance, vitamin E, dimethicone, allantoin, lanolin, sodium PCA, color, vitamin A, vitamin C, glycolic acid, glycerin, petrolatum, propane, isobutane or combinations thereof. Another example of beads which may be included in the formula are Florabeads® as commercialized by International Flora Technologies, Ltd. of Apache Junction, Arizona. The Florabeads® contain hydrogenated jojoba oil which acts as an exfoliant.
While there have been described what are presently believed to be the preferred embodiments of the invention, those skilled in the art will realize that various changes and modifications may be made to the invention without departing from the spirit of the invention, and it is intended to claim all such changes and modifications as fall within the scope of the invention.

Claims (10)

  1. A shaving cream or gel containing microparticles.
  2. A shaving cream or gel which contains additives which act to exfoliate dead skin cells and to remove accumulated debris from the surface of the skin.
  3. A shaving cream or gel according to claim 1 or claim 2, wherein the microparticles are selected from the group consisting of powders, beads, microencapsulated particles or any combination thereof.
  4. A shaving cream or gel according to claim 3, wherein the powders are selected from the group consisting of crushed nut shells, crushed apricot seeds, loofah, talc, magnesium stearate, chalk, kaolin, zinc oxide, titanium oxide, coated powders, beads, micro-silica beads (preferably those with 90/10 ratio), boron nitride, zinc stearate, magnesium oxide, cellulose powders, nylon powder or polyamid resin, silk powder protein, silk coated pigments, calcium carbonate, magnesium carbonate, mica, sericite, organic plastic powders, polymethylmethacrylate beads, polyethylene beads and micropowders, polyvinylidene, polytetrafluoroethylene, polyamides, polyurethane, polystyrene, synthetic clay, magnesium lithium sodium silicate and silica, silicon oxide spheres or combinations thereof.
  5. A shaving cream or gel according to claim 3 or claim 4, wherein the microencapsulated particles are selected from the group consisting of microspheres, microcapsules or combinations thereof.
  6. A shaving cream or gel according to any of claims 3 to 5, wherein the beads contain jojoba oil, mineral oil, sesame oil, silicon oil, aloe vera oil, tocopheryl acetate, fragrance, vitamin E, dimethicone, allantoin, lanolin, sodium PCA, color, vitamin A, vitamin C, glycolic acid, glycerin, petrolatum, propane, isobutane or combinations thereof.
  7. A shaving cream or gel according to claim 5 or 6 when dependent from claim 5, wherein the microencapsulated particles contain jojoba oil, mineral oil, sesame oil, silicone oil, aloe vera oil, tocopheryl acetate, fragrance, vitamin E, dimethicone, allantoin, lanolin, sodium PCA, color, vitamin A, vitamin C, glycolic acid, glycerin, petrolatum, propane, isobutane or combinations thereof.
  8. A shaving cream or gel according to any of claims 3 to 7, wherein the shaving cream or gel is dispensable as an aerosol.
  9. A shaving cream or gel according to any of claims 3 to 8, wherein the shaving cream or gel is dispensable as a post-foaming gel.
  10. A shaving cream or gel according to any of claims 3 to 9, wherein the shaving cream or gel is dispensable as a non-aerosol.
EP97306637A 1996-09-04 1997-08-29 Foam/gel with microbeads and/or fine particles Ceased EP0829259A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70754796A 1996-09-04 1996-09-04
US707547 1996-09-04

Publications (1)

Publication Number Publication Date
EP0829259A1 true EP0829259A1 (en) 1998-03-18

Family

ID=24842150

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97306637A Ceased EP0829259A1 (en) 1996-09-04 1997-08-29 Foam/gel with microbeads and/or fine particles

Country Status (2)

Country Link
EP (1) EP0829259A1 (en)
JP (1) JPH1095720A (en)

Cited By (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10157541A1 (en) * 2001-11-23 2003-06-12 Beiersdorf Ag Skin cleansing preparation
WO2003097006A1 (en) * 2002-05-16 2003-11-27 Beiersdorf Ag Multifunctional cosmetic cleansing preparation
WO2004032888A1 (en) * 2002-10-07 2004-04-22 Ruben Bradley N Shaving compositions
WO2004084851A2 (en) * 2003-03-24 2004-10-07 Exa Sa A treatment composition
WO2005107699A1 (en) 2004-05-07 2005-11-17 Deb Ip Limited Foamed cleanser with suspended particles, a method of producing same, and a dispenser therefore
GB2414485A (en) * 2004-05-27 2005-11-30 Knowledge & Merchandising Inc Shaving composition
US7820152B2 (en) 2005-05-13 2010-10-26 The Gillette Company Shave gel composition containing glyceryl acrylate/acrylic acid copolymer
US8362091B2 (en) 2003-08-04 2013-01-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8435498B2 (en) 2002-10-25 2013-05-07 Foamix Ltd. Penetrating pharmaceutical foam
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8486375B2 (en) 2003-04-28 2013-07-16 Foamix Ltd. Foamable compositions
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US8518378B2 (en) 2003-08-04 2013-08-27 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
DE102012203565A1 (en) 2012-03-07 2013-09-12 Beiersdorf Ag Silica in shaving products
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8709385B2 (en) 2008-01-14 2014-04-29 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US8722021B2 (en) 2002-10-25 2014-05-13 Foamix Ltd. Foamable carriers
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8795635B2 (en) 2006-11-14 2014-08-05 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8900553B2 (en) 2007-12-07 2014-12-02 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US8927026B2 (en) 2011-04-07 2015-01-06 The Procter & Gamble Company Shampoo compositions with increased deposition of polyacrylate microcapsules
US8980292B2 (en) 2011-04-07 2015-03-17 The Procter & Gamble Company Conditioner compositions with increased deposition of polyacrylate microcapsules
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
KR101536255B1 (en) * 2012-11-23 2015-07-24 한국콜마주식회사 Cosmetic compositions for cleaning with the effects of pore tightening and skin elasticity and the method therewith
EP2907498A1 (en) * 2014-02-13 2015-08-19 Induchem Ag Exfoliating cellulose beads and cosmetic uses thereof
US9162085B2 (en) 2011-04-07 2015-10-20 The Procter & Gamble Company Personal cleansing compositions with increased deposition of polyacrylate microcapsules
US9167813B2 (en) 2009-07-29 2015-10-27 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9186642B2 (en) 2010-04-28 2015-11-17 The Procter & Gamble Company Delivery particle
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9320705B2 (en) 2002-10-25 2016-04-26 Foamix Pharmaceuticals Ltd. Sensation modifying topical composition foam
US9364416B2 (en) 2012-11-09 2016-06-14 Johnson & Johnson Consumer Inc. Leave-on compositions containing cellulose materials
US9370478B2 (en) 2012-11-09 2016-06-21 Johnson & Johnson Consumer Inc. Skin care compositions containing cotton and citrus-derived materials
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2016177902A1 (en) * 2015-05-07 2016-11-10 L'oreal Cleansing scrub composition
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US9549889B2 (en) 2012-11-09 2017-01-24 Johnson & Johnson Consumer Inc. Rinse-off skin care compositions containing cellulosic materials
US9622947B2 (en) 2002-10-25 2017-04-18 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9662298B2 (en) 2007-08-07 2017-05-30 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9718069B2 (en) 2014-05-12 2017-08-01 Deb Ip Limited Foam pump
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US9993793B2 (en) 2010-04-28 2018-06-12 The Procter & Gamble Company Delivery particles
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US10556134B2 (en) 2014-12-02 2020-02-11 Conopco, Inc. Stable personal care cream composition

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100710334B1 (en) * 2005-07-08 2007-04-23 엘지전자 주식회사 Method for Manufacturing Plasma Display Panel
WO2008109857A2 (en) * 2007-03-08 2008-09-12 Gardner John P System and method for treating ageing of the skin

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2555443A1 (en) * 1983-09-08 1985-05-31 Spinoglio Mario Acid shaving cream comprising a xanthane gum
EP0385312A2 (en) * 1989-02-28 1990-09-05 Kao Corporation Preshave cosmetic preparation
US5034220A (en) * 1990-06-20 1991-07-23 Gaf Chemicals Corporation Non-aerosol shaving gel
FR2698102A1 (en) * 1992-11-18 1994-05-20 Health Business Dev Cleansing agent for delicate skin and mucous membranes - comprising a polysaccharide polymer and a particulate water insoluble mineral cpd.
FR2700952A1 (en) * 1993-01-29 1994-08-05 Oreal New cosmetic or dermopharmaceutical compositions in the form of aqueous gels modified by the addition of expanded microspheres.
US5587156A (en) * 1996-04-18 1996-12-24 Critical Dimension, Incorporated Shaving compositions containing particulate additives
EP0770373A1 (en) * 1995-10-25 1997-05-02 L'oreal Cosmetic composition containing a monoester of a C4-C10 acid with a C16-C18 alcohol and hollow particles

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2555443A1 (en) * 1983-09-08 1985-05-31 Spinoglio Mario Acid shaving cream comprising a xanthane gum
EP0385312A2 (en) * 1989-02-28 1990-09-05 Kao Corporation Preshave cosmetic preparation
US5034220A (en) * 1990-06-20 1991-07-23 Gaf Chemicals Corporation Non-aerosol shaving gel
FR2698102A1 (en) * 1992-11-18 1994-05-20 Health Business Dev Cleansing agent for delicate skin and mucous membranes - comprising a polysaccharide polymer and a particulate water insoluble mineral cpd.
FR2700952A1 (en) * 1993-01-29 1994-08-05 Oreal New cosmetic or dermopharmaceutical compositions in the form of aqueous gels modified by the addition of expanded microspheres.
EP0770373A1 (en) * 1995-10-25 1997-05-02 L'oreal Cosmetic composition containing a monoester of a C4-C10 acid with a C16-C18 alcohol and hollow particles
US5587156A (en) * 1996-04-18 1996-12-24 Critical Dimension, Incorporated Shaving compositions containing particulate additives

Cited By (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
DE10157541A1 (en) * 2001-11-23 2003-06-12 Beiersdorf Ag Skin cleansing preparation
WO2003097006A1 (en) * 2002-05-16 2003-11-27 Beiersdorf Ag Multifunctional cosmetic cleansing preparation
WO2004032888A1 (en) * 2002-10-07 2004-04-22 Ruben Bradley N Shaving compositions
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9492412B2 (en) 2002-10-25 2016-11-15 Foamix Pharmaceuticals Ltd. Penetrating pharmaceutical foam
US9713643B2 (en) 2002-10-25 2017-07-25 Foamix Pharmaceuticals Ltd. Foamable carriers
US9320705B2 (en) 2002-10-25 2016-04-26 Foamix Pharmaceuticals Ltd. Sensation modifying topical composition foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US11033491B2 (en) 2002-10-25 2021-06-15 Vyne Therapeutics Inc. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US10322085B2 (en) 2002-10-25 2019-06-18 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8435498B2 (en) 2002-10-25 2013-05-07 Foamix Ltd. Penetrating pharmaceutical foam
US10821077B2 (en) 2002-10-25 2020-11-03 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8840869B2 (en) 2002-10-25 2014-09-23 Foamix Ltd. Body cavity foams
US9622947B2 (en) 2002-10-25 2017-04-18 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8741265B2 (en) 2002-10-25 2014-06-03 Foamix Ltd. Penetrating pharmaceutical foam
US8722021B2 (en) 2002-10-25 2014-05-13 Foamix Ltd. Foamable carriers
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
WO2004084851A2 (en) * 2003-03-24 2004-10-07 Exa Sa A treatment composition
WO2004084851A3 (en) * 2003-03-24 2004-11-11 Exa Sa A treatment composition
US8486375B2 (en) 2003-04-28 2013-07-16 Foamix Ltd. Foamable compositions
US8362091B2 (en) 2003-08-04 2013-01-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8703105B2 (en) 2003-08-04 2014-04-22 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9636405B2 (en) 2003-08-04 2017-05-02 Foamix Pharmaceuticals Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8518378B2 (en) 2003-08-04 2013-08-27 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9101662B2 (en) 2003-08-04 2015-08-11 Foamix Pharmaceuticals Ltd. Compositions with modulating agents
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US9050253B2 (en) 2003-08-04 2015-06-09 Foamix Pharmaceuticals Ltd. Oleaginous pharmaceutical and cosmetic foam
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8281958B2 (en) 2004-05-07 2012-10-09 Deb Ip Limited Method of producing foamed cleanser with suspended particles therein and a dispenser therefore
EP1750662A1 (en) * 2004-05-07 2007-02-14 Deb IP Limited Foamed cleanser with suspended particles, a method of producing same, and a dispenser therefore
AU2005239772B2 (en) * 2004-05-07 2011-09-15 Deb Ip Limited Foamed cleanser with suspended particles
EP1750662A4 (en) * 2004-05-07 2010-06-09 Deb Ip Ltd Foamed cleanser with suspended particles, a method of producing same, and a dispenser therefore
US10736824B2 (en) 2004-05-07 2020-08-11 Deb Ip Limited Foamed cleanser with suspended particles
WO2005107699A1 (en) 2004-05-07 2005-11-17 Deb Ip Limited Foamed cleanser with suspended particles, a method of producing same, and a dispenser therefore
US8002151B2 (en) 2004-05-07 2011-08-23 Deb Ip Limited Method of producing foamed cleanser with suspended particles therein and a dispenser therefore
GB2414485A (en) * 2004-05-27 2005-11-30 Knowledge & Merchandising Inc Shaving composition
US7820152B2 (en) 2005-05-13 2010-10-26 The Gillette Company Shave gel composition containing glyceryl acrylate/acrylic acid copolymer
US8795635B2 (en) 2006-11-14 2014-08-05 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US9682021B2 (en) 2006-11-14 2017-06-20 Foamix Pharmaceuticals Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US10369102B2 (en) 2007-08-07 2019-08-06 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9662298B2 (en) 2007-08-07 2017-05-30 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US11103454B2 (en) 2007-08-07 2021-08-31 Vyne Therapeutics Inc. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US8900553B2 (en) 2007-12-07 2014-12-02 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US9161916B2 (en) 2007-12-07 2015-10-20 Foamix Pharmaceuticals Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US9549898B2 (en) 2007-12-07 2017-01-24 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US11433025B2 (en) 2007-12-07 2022-09-06 Vyne Therapeutics Inc. Oil foamable carriers and formulations
US9795564B2 (en) 2007-12-07 2017-10-24 Foamix Pharmaceuticals Ltd. Oil-based foamable carriers and formulations
US8709385B2 (en) 2008-01-14 2014-04-29 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US10213384B2 (en) 2009-04-28 2019-02-26 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10363216B2 (en) 2009-04-28 2019-07-30 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10588858B2 (en) 2009-04-28 2020-03-17 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US11219631B2 (en) 2009-07-29 2022-01-11 Vyne Pharmaceuticals Inc. Foamable compositions, breakable foams and their uses
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US10350166B2 (en) 2009-07-29 2019-07-16 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9167813B2 (en) 2009-07-29 2015-10-27 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9572775B2 (en) 2009-07-29 2017-02-21 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US10092588B2 (en) 2009-07-29 2018-10-09 Foamix Pharmaceuticals Ltd. Foamable compositions, breakable foams and their uses
US10213512B2 (en) 2009-10-02 2019-02-26 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10821187B2 (en) 2009-10-02 2020-11-03 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US9675700B2 (en) 2009-10-02 2017-06-13 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10967063B2 (en) 2009-10-02 2021-04-06 Vyne Therapeutics Inc. Surfactant-free, water-free formable composition and breakable foams and their uses
US10946101B2 (en) 2009-10-02 2021-03-16 Vyne Therapeutics Inc. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10835613B2 (en) 2009-10-02 2020-11-17 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8865139B1 (en) 2009-10-02 2014-10-21 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US10610599B2 (en) 2009-10-02 2020-04-07 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10517882B2 (en) 2009-10-02 2019-12-31 Foamix Pharmaceuticals Ltd. Method for healing of an infected acne lesion without scarring
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
US10086080B2 (en) 2009-10-02 2018-10-02 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10463742B2 (en) 2009-10-02 2019-11-05 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US8945516B2 (en) 2009-10-02 2015-02-03 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10137200B2 (en) 2009-10-02 2018-11-27 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US8992896B2 (en) 2009-10-02 2015-03-31 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10322186B2 (en) 2009-10-02 2019-06-18 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10265404B2 (en) 2009-10-02 2019-04-23 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10238746B2 (en) 2009-10-02 2019-03-26 Foamix Pharmaceuticals Ltd Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9186642B2 (en) 2010-04-28 2015-11-17 The Procter & Gamble Company Delivery particle
US9993793B2 (en) 2010-04-28 2018-06-12 The Procter & Gamble Company Delivery particles
US11096875B2 (en) 2010-04-28 2021-08-24 The Procter & Gamble Company Delivery particle
US9561169B2 (en) 2011-04-07 2017-02-07 The Procter & Gamble Company Conditioner compositions with increased deposition of polyacrylate microcapsules
US9162085B2 (en) 2011-04-07 2015-10-20 The Procter & Gamble Company Personal cleansing compositions with increased deposition of polyacrylate microcapsules
US10143632B2 (en) 2011-04-07 2018-12-04 The Procter And Gamble Company Shampoo compositions with increased deposition of polyacrylate microcapsules
US8980292B2 (en) 2011-04-07 2015-03-17 The Procter & Gamble Company Conditioner compositions with increased deposition of polyacrylate microcapsules
US8927026B2 (en) 2011-04-07 2015-01-06 The Procter & Gamble Company Shampoo compositions with increased deposition of polyacrylate microcapsules
DE102012203565A1 (en) 2012-03-07 2013-09-12 Beiersdorf Ag Silica in shaving products
WO2013131780A2 (en) 2012-03-07 2013-09-12 Beiersdorf Ag Silicon dioxide in shaving products
US9220666B2 (en) 2012-03-07 2015-12-29 Beiersdorf Ag Silicon dioxide in shaving products
WO2013131780A3 (en) * 2012-03-07 2014-04-10 Beiersdorf Ag Silicon dioxide in shaving products
US9549889B2 (en) 2012-11-09 2017-01-24 Johnson & Johnson Consumer Inc. Rinse-off skin care compositions containing cellulosic materials
US9737473B2 (en) 2012-11-09 2017-08-22 Johnson & Johnson Consumer Inc. Leave-on compositions containing cellulose materials
US9549890B2 (en) 2012-11-09 2017-01-24 Johnson & Johnson Consumer Inc. Rinse-off skin care compositions containing cellulosic materials
US9370478B2 (en) 2012-11-09 2016-06-21 Johnson & Johnson Consumer Inc. Skin care compositions containing cotton and citrus-derived materials
US9364416B2 (en) 2012-11-09 2016-06-14 Johnson & Johnson Consumer Inc. Leave-on compositions containing cellulose materials
KR101536255B1 (en) * 2012-11-23 2015-07-24 한국콜마주식회사 Cosmetic compositions for cleaning with the effects of pore tightening and skin elasticity and the method therewith
EP2907498A1 (en) * 2014-02-13 2015-08-19 Induchem Ag Exfoliating cellulose beads and cosmetic uses thereof
US9718069B2 (en) 2014-05-12 2017-08-01 Deb Ip Limited Foam pump
US10556134B2 (en) 2014-12-02 2020-02-11 Conopco, Inc. Stable personal care cream composition
US10980714B2 (en) 2015-05-07 2021-04-20 L'oreal Cleansing scrub composition
WO2016177902A1 (en) * 2015-05-07 2016-11-10 L'oreal Cleansing scrub composition
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US11324691B2 (en) 2016-09-08 2022-05-10 Journey Medical Corporation Compositions and methods for treating rosacea and acne
US10849847B2 (en) 2016-09-08 2020-12-01 Foamix Pharamaceuticals Ltd. Compositions and methods for treating rosacea and acne

Also Published As

Publication number Publication date
JPH1095720A (en) 1998-04-14

Similar Documents

Publication Publication Date Title
EP0829259A1 (en) Foam/gel with microbeads and/or fine particles
US5756081A (en) Shaving compositions containing particulate additives
JP2552293B2 (en) Free-flowing powdery cosmetics
KR100342450B1 (en) Solid warming pulverulent composition to be hydrated for caring for or cleaning the skin
EP0307723B1 (en) Encapsulation of adjuvants within antiperspirant active
EP1642924B1 (en) Composite particle and process for producing the same
JP2895627B2 (en) Cosmetic composition
JPH057062B2 (en)
CN110603223B (en) Hollow particles and cosmetics
CA1289034C (en) Dry aerosol foam
CN109789058B (en) Skin cleansing compositions comprising color stable abrasive particles
US5939079A (en) Process for the dispersion by high-pressure homogenization of pulverulent fillers in a vehicle composed of at least one fatty phase, compositions obtained and uses
EP0896524B1 (en) Topical compositions comprising dispersed surfactant complex
JP3430456B2 (en) Hydrating solid foamable powder composition for skin care or cleansing
EP0901369A1 (en) Topical compositions comprising dispersed surfactant complex
JP2002020739A (en) Exothermic particle
US5281413A (en) Antiperspirant stick containing a macroporous polymer
CA2363156C (en) Deodorant compositions
JPH01143820A (en) Deodorant
JPH03106809A (en) Cellulosic scrubbing material
JP2001096146A (en) Microcapsule and method for production of the same
CN111447913A (en) Composition having polyurethane microcapsules with improved long-lasting odor benefits
JPH057362B2 (en)
JP4597469B2 (en) Porous particles and process for producing the same
JP2003212723A (en) Granulated composition and cosmetic containing the same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970912

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB

AX Request for extension of the european patent

Free format text: AL;LT;LV;RO;SI

AKX Designation fees paid

Free format text: DE FR GB

RBV Designated contracting states (corrected)

Designated state(s): DE FR GB

17Q First examination report despatched

Effective date: 20011029

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20040604